Physician profile
Imran Trimzi
NPI 1467502773
$1,435.06
in general payments reported to CMS, 2019-2025
18 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $25.07 · 2021: $30.63 · 2022: $205 · 2023: $162 · 2024: $449 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $286.45 | 2020-2025 | Abilify Mycite, Rexulti |
| Neurocrine Biosciences, INC. | $226.33 | 2022-2025 | Ingrezza |
| Abbvie INC. | $200.38 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $116.76 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $116.53 | 2019-2022 | |
| Allergan, INC. | $85.75 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.75 | 2023-2025 | Caplyta |
| Alkermes, INC. | $65.96 | 2019-2025 | Lybalvi |
| Teva Pharmaceuticals USA, INC. | $56.66 | 2023-2024 | Austedo Xr |
| Axsome Therapeutics, INC. | $41.49 | 2024-2025 | Auvelity |
| Corium, LLC | $34.73 | 2022 | |
| Bausch Health US, LLC | $22.18 | 2022 | |
| Neuronetics, INC. | $21.73 | 2019 | |
| Lundbeck LLC | $21.31 | 2019 | |
| Shire North American Group INC | $14.33 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $14.22 | 2024 | Quviviq |
| Indivior INC. | $14.01 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Trimzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.